This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.

PharmacyChecker files reply in support of dismissing counterclaims in US antitrust case against National Association of Boards of Pharmacy

( January 10, 2022, 22:31 GMT | Official Statement) -- MLex Summary: PharmacyChecker filed a reply in support of its motion to dismiss counterclaims accusing it of false and misleading arguments filed by the National Association of Boards of Pharmacy, arguing that NABP has failed to allege commercial injury proximately caused by any commercial advertising. PharmacyChecker is accusing the board and others of engaging in an illegal group boycott to prevent it from competing....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections